Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ACON - Aclarion, Inc.

Previous close
0.1427
0.011   7.779%

Share volume: 1,600
Last Updated: Thu 26 Dec 2024 07:16:14 PM CET
Data Processing, Hosting, and Related Services: 14.75%

PREVIOUS CLOSE
CHG
CHG%
$0.13
0.01
8.43%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
8%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 20%
Performance
5 Days
1.11%
1 Month
-29.36%
3 Months
-26.90%
6 Months
-58.71%
1 Year
-96.38%
2 Year
-98.33%
Key data
Stock price
$0.14
P/E Ratio 
0.00
DAY RANGE
$0.13 - $0.13
EPS 
$0.00
52 WEEK RANGE
$0.11 - $6.75
52 WEEK CHANGE
-$96.37
MARKET CAP 
1.803 M
YIELD 
N/A
SHARES OUTSTANDING 
8.611 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
-0.83
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$918,914
AVERAGE 30 VOLUME 
$1,173,733
Company detail
CEO: Brent Ness
Region: US
Website: aclarion.com
Employees: 7
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Data Processing, Hosting, and Related Services
Sector: Information

Aclarion, Inc. develops software application for magnetic resonance spectroscopy (MRS) in the U.S. It offers NOCISCAN-LS Post-Processor suite, NOCICALC-LS, and NOCIGRAM-LS. The company was formerly known as Nocimed, which changed its name to ACLarion in December 2021.

Recent news